These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 10544058)
1. New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPARdelta). Lampen A; Siehler S; Ellerbeck U; Göttlicher M; Nau H Toxicol Appl Pharmacol; 1999 Nov; 160(3):238-49. PubMed ID: 10544058 [TBL] [Abstract][Full Text] [Related]
2. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods. Lampen A; Göttlicher M; Nau H ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687 [TBL] [Abstract][Full Text] [Related]
3. Modulation of peroxisome proliferator-activated receptor delta activity affects neural cell adhesion molecule and polysialyltransferase ST8SiaIV induction by teratogenic valproic acid analogs in F9 cell differentiation. Lampen A; Grimaldi PA; Nau H Mol Pharmacol; 2005 Jul; 68(1):193-203. PubMed ID: 15829700 [TBL] [Abstract][Full Text] [Related]
4. Induction of differentiation in F9 cells and activation of peroxisome proliferator-activated receptor delta by valproic acid and its teratogenic derivatives. Werling U; Siehler S; Litfin M; Nau H; Göttlicher M Mol Pharmacol; 2001 May; 59(5):1269-76. PubMed ID: 11306712 [TBL] [Abstract][Full Text] [Related]
5. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives. Eikel D; Lampen A; Nau H Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903 [TBL] [Abstract][Full Text] [Related]
6. Anticonvulsant profile and teratogenic evaluation of potent new analogues of a valproic acid urea derivative in NMRI mice. Okada A; Noyori H; Yagen B; Shimshoni JA; Bialer M; Fujiwara M Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):394-401. PubMed ID: 19830722 [TBL] [Abstract][Full Text] [Related]
7. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity. Gravemann U; Volland J; Nau H Neurotoxicol Teratol; 2008; 30(5):390-4. PubMed ID: 18455366 [TBL] [Abstract][Full Text] [Related]
8. Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect. Bojic U; Elmazar MM; Hauck RS; Nau H Chem Res Toxicol; 1996; 9(5):866-70. PubMed ID: 8828922 [TBL] [Abstract][Full Text] [Related]
9. Teratogenic phthalate esters and metabolites activate the nuclear receptors PPARs and induce differentiation of F9 cells. Lampen A; Zimnik S; Nau H Toxicol Appl Pharmacol; 2003 Apr; 188(1):14-23. PubMed ID: 12668118 [TBL] [Abstract][Full Text] [Related]
10. Tetramethylcyclopropyl analogue of the leading antiepileptic drug, valproic acid: evaluation of the teratogenic effects of its amide derivatives in NMRI mice. Okada A; Onishi Y; Yagen B; Shimshoni JA; Kaufmann D; Bialer M; Fujiwara M Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):610-21. PubMed ID: 18671279 [TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor delta is a specific sensor for teratogenic valproic acid derivatives. Lampen A; Carlberg C; Nau H Eur J Pharmacol; 2001 Nov; 431(1):25-33. PubMed ID: 11716839 [TBL] [Abstract][Full Text] [Related]
12. Valproic acid-induced deregulation in vitro of genes associated in vivo with neural tube defects. Jergil M; Kultima K; Gustafson AL; Dencker L; Stigson M Toxicol Sci; 2009 Mar; 108(1):132-48. PubMed ID: 19136453 [TBL] [Abstract][Full Text] [Related]
13. Teratogenicity of valproate conjugates with anticonvulsant activity in mice. Spiegelstein O; Chatterjie N; Alexander G; Finnell RH Epilepsy Res; 2003 Dec; 57(2-3):145-52. PubMed ID: 15013055 [TBL] [Abstract][Full Text] [Related]
14. Amidic modification of valproic acid reduces skeletal teratogenicity in mice. Okada A; Kurihara H; Aoki Y; Bialer M; Fujiwara M Birth Defects Res B Dev Reprod Toxicol; 2004 Feb; 71(1):47-53. PubMed ID: 14991910 [TBL] [Abstract][Full Text] [Related]
15. Short-time gene expression response to valproic acid and valproic acid analogs in mouse embryonic stem cells. Jergil M; Forsberg M; Salter H; Stockling K; Gustafson AL; Dencker L; Stigson M Toxicol Sci; 2011 Jun; 121(2):328-42. PubMed ID: 21427059 [TBL] [Abstract][Full Text] [Related]
16. Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Ornoy A Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988 [TBL] [Abstract][Full Text] [Related]
17. S-2-pentyl-4-pentynoic hydroxamic acid and its metabolite s-2-pentyl-4-pentynoic acid in the NMRI-exencephaly-mouse model: pharmacokinetic profiles, teratogenic effects, and histone deacetylase inhibition abilities of further valproic acid hydroxamates and amides. Eikel D; Hoffmann K; Zoll K; Lampen A; Nau H Drug Metab Dispos; 2006 Apr; 34(4):612-20. PubMed ID: 16415118 [TBL] [Abstract][Full Text] [Related]
18. Potent anticonvulsant urea derivatives of constitutional isomers of valproic acid. Shimshoni JA; Bialer M; Wlodarczyk B; Finnell RH; Yagen B J Med Chem; 2007 Dec; 50(25):6419-27. PubMed ID: 17994680 [TBL] [Abstract][Full Text] [Related]
19. Effects of the antiepileptic drug valproic acid on the development of the axolotl (Ambystoma mexicanum): histological investigations. Krätke R; Kirschbaum F Teratog Carcinog Mutagen; 1996; 16(3):149-67. PubMed ID: 8983118 [TBL] [Abstract][Full Text] [Related]
20. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice. Dawson JE; Raymond AM; Winn LM Toxicol Appl Pharmacol; 2006 Mar; 211(2):124-32. PubMed ID: 16112698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]